ZUG, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) — The attached notification relates to the purchase of ordinary shares by a member of the Company’s Board of Directors. Attachment …
ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…
Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…
NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…
Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…
Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…
Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…